Kyunggi-do, South Korea

Sang Joon Lee

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 117(Granted Patents)


Location History:

  • Kyunggi-do, KR (2000)
  • Kunpo, KR (2001)

Company Filing History:


Years Active: 2000-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Sang Joon Lee

Introduction

Sang Joon Lee is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of three patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Sang Joon Lee's latest patents include a process for preparing camptothecin derivatives. This process involves the synthesis of camptothecin derivatives of a specific formula, which are crucial for various medical applications. Another significant patent focuses on fumagillol derivatives and the processes for preparing these compounds. These compounds are recognized for their potential as angiogenesis-inhibiting agents. Additionally, the patent discloses a pharmaceutical composition that includes a compound of the specified formula, aimed at inhibiting angiogenesis in mammals.

Career Highlights

Sang Joon Lee is currently associated with Chong Kun Dang Corporation, a prominent pharmaceutical company in South Korea. His work at the company has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Throughout his career, Sang Joon Lee has collaborated with notable colleagues, including Jung Woo Kim and Soon Kil Ahn. These collaborations have further enriched his research and development efforts.

Conclusion

Sang Joon Lee's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the development of therapeutic agents, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…